LABETALOL HYDROCHLORIDE | A075113 | AIPING PHARMACEUTICAL INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition Amendment from Hyman, Phelps & McNamara, P.C. FDA-2025-P-7056 · 9 docket documents I don't have access to the specific content of the petition you're referring to. The title you provided indicates this is a suitability petition amendment filed by Hyman, Phelps & McNamara, P.C., but without the actual petition text detailing the drug product, requested action, and regulatory mechan | Suitability | 2026-07-02 | Denied | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.